RBPJP7

Across TCGA pan-cancer cohorts, RBPJP7 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RBPJP7 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RBPJP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RBPJP7 expression acts as an unfavorable survival marker.

UCEC, BLCA, and ACC are the cancer types where RBPJP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.260	0.698	.001	108	view →
BLCA	OS	Tertile	All	0.235	0.697	<.001	78	view →
ACC	DFS	Tertile	All	0.068	0.667	.005	36	view →
PCPG	DFS	Tertile	All	0.204	0.797	.001	30	view →
SKCM	DFS	Tertile	III,IV	0.106	0.655	.002	27	view →
THYM	OS	Tertile	All	0.621	0.977	.001	24	view →
LUAD	DFS	Tertile	IV	0.357	0.710	.019	18	view →
THCA	DFS	Tertile	III,IV	0.116	0.856	<.001	9	view →
STAD	OS	Quartile	All	0.465	0.588	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RBPJP7–UCEC (OS)

Open the UCEC breakdown →